Acupuncture Reduces Crying in Infants With Colic

Share this content:
Acupuncture Reduces Crying in Infants With Colic
Acupuncture Reduces Crying in Infants With Colic

TUESDAY, Jan. 17, 2017 (HealthDay News) -- Acupuncture may be an effective treatment option for infantile colic, according to a study published online Jan. 16 in Acupuncture in Medicine.

Kajsa Landgren, Ph.D., and Inger Hallström, R.N., of Lund University in Sweden, randomly assigned 147 infants with colic between 2 and 8 weeks old to one of three groups of 49 babies each. One group received minimal acupuncture, which consisted of a single needle at one acupuncture point for two to five seconds. A second group was given tailored acupuncture at a maximum of five acupuncture points for up to 30 seconds with mild electric stimulation. The third group had no acupuncture. After treatment, parents kept a detailed diary of how often and how long their infant cried.

In all, 144 babies completed the two-week trial. The amount of excessive crying dropped in all groups, which was not unexpected, the researchers said. But the reduction in crying was greater among infants who received acupuncture than those who didn't. After two weeks, among those who received minimal acupuncture, 16 babies still had colic. Of those who received tailored acupuncture, 21 were still crying. But 31 of those not given acupuncture were still colicky, the researchers found. Parents continued to chart crying bouts for six days after the final clinic visit, and the differences between the three groups remained.

The infants seemed to tolerate the acupuncture fairly well, the investigators found. Out of 388 treatments, the infants didn't cry at all during 200 of them, and cried for less than a minute during 157 treatments. Only 31 treatments triggered a crying jag of more than one minute.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »